Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 142 articles:
HTML format



Single Articles


    January 2022
  1. FU F, Pietropaolo M, Cui L, Pandit S, et al
    Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.
    PLoS One. 2022;17:e0256512.
    PubMed     Abstract available


  2. MOL D, Boersma AM, Berger WR, Khan M, et al
    Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
    PLoS One. 2022;17:e0261841.
    PubMed     Abstract available


  3. CHRISTERSSON C, Held C, Modica A, Westerbergh J, et al
    Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.
    PLoS One. 2022;17:e0262580.
    PubMed     Abstract available


  4. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    PubMed     Abstract available


  5. FASTNER C, Szabo K, Samartzi M, Kruska M, et al
    Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
    PLoS One. 2022;17:e0264122.
    PubMed     Abstract available


  6. CHOI BJ, Koo Y, Kim TY, Lim HS, et al
    Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
    PLoS One. 2022;17:e0263117.
    PubMed     Abstract available


  7. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available


  8. CIMINATA G, Geue C, Wu O, Deidda M, et al
    Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.
    PLoS One. 2022;17:e0262293.
    PubMed     Abstract available


  9. NATHANIA J, Woo BFY, Cher BP, Toh KY, et al
    Patient perspectives of the Self-management and Educational Technology tool for Atrial Fibrillation (SETAF): A mixed-methods study in Singapore.
    PLoS One. 2022;17:e0262033.
    PubMed     Abstract available


  10. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available


  11. MUNIR MB, Hlavacek P, Keshishian A, Guo JD, et al
    Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    PLoS One. 2022;17:e0263903.
    PubMed     Abstract available


  12. MARTINEZ-CAMPELO L, Cruz R, Blanco-Verea A, Moscoso I, et al
    Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome.
    PLoS One. 2022;17:e0263469.
    PubMed     Abstract available


  13. SHABBIR MA, Saad Shaukat MH, Ehtesham M, Murawski S, et al
    Bifascicular block in unexplained syncope is underrecognized and under-evaluated: A single-center audit of ESC guidelines adherence.
    PLoS One. 2022;17:e0263727.
    PubMed     Abstract available


  14. NASIMI F, Yazdchi M
    LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators.
    PLoS One. 2022;17:e0264405.
    PubMed     Abstract available


  15. RUSS D, Williams JA, Cardoso VR, Bravo-Merodio L, et al
    Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models.
    PLoS One. 2022;17:e0263390.
    PubMed     Abstract available


  16. PARK J, Jung JH, Choi EK, Lee SW, et al
    Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    PLoS One. 2022;17:e0264538.
    PubMed     Abstract available


  17. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available


  18. OCAK G, Khairoun M, Khairoun O, Bos WJW, et al
    Chronic kidney disease and atrial fibrillation: A dangerous combination.
    PLoS One. 2022;17:e0266046.
    PubMed     Abstract available


  19. HIROSHI I, Natsuko SY, Yutaka I, Masayori S, et al
    Frequency of hemorrhage after tooth extraction in patients treated with a direct oral anticoagulant: A multicenter cross-sectional study.
    PLoS One. 2022;17:e0266011.
    PubMed     Abstract available


  20. MATSUNAGA-LEE Y, Egami Y, Matsumoto S, Masunaga N, et al
    Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.
    PLoS One. 2022;17:e0263938.
    PubMed     Abstract available


  21. KOGE J, Yamagami H, Toyoda K, Yasaka M, et al
    Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.
    PLoS One. 2022;17:e0264760.
    PubMed     Abstract available


  22. ESCOBAR CERVANTES C, Marti-Almor J, Cabeza AIP, Bowrin K, et al
    Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
    PLoS One. 2022;17:e0266658.
    PubMed     Abstract available


  23. NAKAI M, Iwanaga Y, Sumita Y, Wada S, et al
    Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset.
    PLoS One. 2022;17:e0264390.
    PubMed     Abstract available


  24. SAKAMOTO K, Mukai Y, Kawai S, Nagaoka K, et al
    Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation.
    PLoS One. 2022;17:e0264894.
    PubMed     Abstract available


  25. UHE T, Stegmann T, Langhammer R, Dagres N, et al
    Signs of left atrial disease and 10-year risk of atrial fibrillation.
    PLoS One. 2022;17:e0266848.
    PubMed     Abstract available


  26. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed     Abstract available


  27. WEI N, Tolkacheva EG
    Mechanisms of arrhythmia termination during acute myocardial ischemia: Role of ephaptic coupling and complex geometry of border zone.
    PLoS One. 2022;17:e0264570.
    PubMed     Abstract available


  28. ARNOLD R, Hofer E, Haas J, Sanchez-Quintana D, et al
    Diversity and complexity of the cavotricuspid isthmus in rabbits: A novel scheme for classification and geometrical transformation of anatomical structures.
    PLoS One. 2022;17:e0264625.
    PubMed     Abstract available


  29. YAMADA Y, Minatoguchi S, Baba S, Shibata S, et al
    Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
    PLoS One. 2022;17:e0265347.
    PubMed     Abstract available


  30. WATSON GM, Sutherland J, Lacey C, Bridgman PG, et al
    A randomised cross-over trial of QT response to hyperventilation-induced anxiety and diaphragmatic breathing in patients with stress cardiomyopathy and in control patients.
    PLoS One. 2022;17:e0265607.
    PubMed     Abstract available


  31. WANG Y, Han Z, Wang Y, Yan Y, et al
    Risk factors of sitting-induced tachycardia syndrome in children and adolescents.
    PLoS One. 2022;17:e0265364.
    PubMed     Abstract available


  32. ALONSO A, Alam AB, Kamel H, Subbian V, et al
    Epidemiology of atrial fibrillation in the All of Us Research Program.
    PLoS One. 2022;17:e0265498.
    PubMed     Abstract available


  33. SILAND JE, Geelhoed B, Roselli C, Wang B, et al
    Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.
    PLoS One. 2022;17:e0268768.
    PubMed     Abstract available


  34. IKEUCHI Y, Ochi H, Motoda C, Tokuyama T, et al
    Plasma MicroRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome.
    PLoS One. 2022;17:e0261390.
    PubMed     Abstract available


  35. SENOO K, Yukawa A, Ohkura T, Shoji K, et al
    Screening for untreated atrial fibrillation in the elderly population: A community-based study.
    PLoS One. 2022;17:e0269506.
    PubMed     Abstract available


  36. JANG HJ, Lee D, Kim TH, Kim JS, et al
    Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy.
    PLoS One. 2022;17:e0269262.
    PubMed     Abstract available


  37. DING M, Li QF, Yin G, Liu JL, et al
    Effects of Drosophila melanogaster regular exercise and apolipoprotein B knockdown on abnormal heart rhythm induced by a high-fat diet.
    PLoS One. 2022;17:e0262471.
    PubMed     Abstract available


  38. SAMUEL JP, Wootton SH, Holder T, Molony D, et al
    A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.
    PLoS One. 2022;17:e0269387.
    PubMed     Abstract available


  39. EROGLU TE, Blom MT, Souverein PC, Yasmina A, et al
    Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
    PLoS One. 2022;17:e0267016.
    PubMed     Abstract available


  40. KORNEJ J, Friedrich K, Schroeter ML, Witte AV, et al
    PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study.
    PLoS One. 2022;17:e0269815.
    PubMed     Abstract available


  41. MOON I, Go TH, Kim JY, Kang DR, et al
    Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    PLoS One. 2022;17:e0268113.
    PubMed     Abstract available


  42. ROGERS JD, Higuera L, Rosemas SC, Cheng YJ, et al
    Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients.
    PLoS One. 2022;17:e0270398.
    PubMed     Abstract available


  43. FALKENBERG M, Coleman JA, Dobson S, Hickey DJ, et al
    Identifying locations susceptible to micro-anatomical reentry using a spatial network representation of atrial fibre maps.
    PLoS One. 2022;17:e0267166.
    PubMed     Abstract available


  44. DARVISHI A, Sadeghipour P, Darrudi A, Daroudi R, et al
    Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran.
    PLoS One. 2022;17:e0270642.
    PubMed     Abstract available


  45. FARRAG NA, Thornhill RE, Prato FS, Skanes AC, et al
    Assessment of left atrial fibrosis progression in canines following rapid ventricular pacing using 3D late gadolinium enhanced CMR images.
    PLoS One. 2022;17:e0269592.
    PubMed     Abstract available


  46. MOKGOKONG R, Schnabel R, Witt H, Miller R, et al
    Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries.
    PLoS One. 2022;17:e0269867.
    PubMed     Abstract available


  47. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available


  48. SU CH, Lo CH, Chen HH, Tsai CF, et al
    CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke.
    PLoS One. 2022;17:e0270823.
    PubMed     Abstract available


  49. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    PubMed     Abstract available


  50. KABUS D, Arno L, Leenknegt L, Panfilov AV, et al
    Numerical methods for the detection of phase defect structures in excitable media.
    PLoS One. 2022;17:e0271351.
    PubMed     Abstract available


  51. NAKAJIMA T, Kawabata-Iwakawa R, Tamura S, Hasegawa H, et al
    Novel CACNA1C R511Q mutation, located in domain - linker, causes non-syndromic type-8 long QT syndrome.
    PLoS One. 2022;17:e0271796.
    PubMed     Abstract available


  52. CHOI JH, Park SJ, Park KM, Kim JS, et al
    Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: A comparison with radiofrequency ablation.
    PLoS One. 2022;17:e0265482.
    PubMed     Abstract available


  53. DUAN J, Wang Q, Zhang B, Liu C, et al
    Accurate detection of atrial fibrillation events with R-R intervals from ECG signals.
    PLoS One. 2022;17:e0271596.
    PubMed     Abstract available


  54. PRADELLA M, Anastasopoulos C, Yang S, Moor M, et al
    Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation.
    PLoS One. 2022;17:e0272011.
    PubMed     Abstract available


  55. PALA E, Bustamante A, Clua-Espuny JL, Acosta J, et al
    Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study.
    PLoS One. 2022;17:e0273571.
    PubMed     Abstract available


  56. AMAMI K, Yoshihisa A, Horikoshi Y, Yamada S, et al
    Utility of a novel wearable electrode embedded in an undershirt for electrocardiogram monitoring and detection of arrhythmias.
    PLoS One. 2022;17:e0273541.
    PubMed     Abstract available


  57. ALKHALFAN F, Gyftopoulos A, Chen YJ, Williams CH, et al
    Identifying genetic variants associated with the ICD10 (International Classification of Diseases10)-based diagnosis of cerebrovascular disease using a large-scale biomedical database.
    PLoS One. 2022;17:e0273217.
    PubMed     Abstract available


  58. DE MARCO F, Ferrucci F, Risi M, Tortora G, et al
    Classification of QRS complexes to detect Premature Ventricular Contraction using machine learning techniques.
    PLoS One. 2022;17:e0268555.
    PubMed     Abstract available


  59. CHANG YK, Fan HC, Lin CC, Wang YH, et al
    Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.
    PLoS One. 2022;17:e0273646.
    PubMed     Abstract available


  60. GO MT, George AM, Tahsin B, Fogelfeld L, et al
    Tachycardia in hyperthyroidism: Not so common.
    PLoS One. 2022;17:e0273724.
    PubMed     Abstract available


  61. DE LUSIGNAN S, Hobbs FDR, Liyanage H, Sherlock J, et al
    Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: Sentinel network database study.
    PLoS One. 2022;17:e0265998.
    PubMed     Abstract available


  62. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    PubMed     Abstract available


  63. KUMAR M A, Chakrapani A
    Classification of ECG signal using FFT based improved Alexnet classifier.
    PLoS One. 2022;17:e0274225.
    PubMed     Abstract available


  64. BEIER L, Lu S, Franca LR, Marler S, et al
    Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
    PLoS One. 2022;17:e0274237.
    PubMed     Abstract available


  65. LIU Y, Sun XX, Du WY, Chen TT, et al
    Intensive versus conservative glycemic control in patients undergoing coronary artery bypass graft surgery: A protocol for systematic review of randomised controlled trials.
    PLoS One. 2022;17:e0276228.
    PubMed     Abstract available


  66. CHOI SH, Kim M, Kim H, Kim DH, et al
    Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
    PLoS One. 2022;17:e0275103.
    PubMed     Abstract available


  67. TEPPO K, Jaakkola J, Langen VL, Biancari F, et al
    Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    PLoS One. 2022;17:e0276612.
    PubMed     Abstract available


  68. CELIK E, Hokamp NG, Goertz L, Fehske W, et al
    Is there an association between left atrial outpouching structures and recurrence of atrial fibrillation after catheter ablation?
    PLoS One. 2022;17:e0276369.
    PubMed     Abstract available


  69. NA SJ, Yang JH, Ko RE, Chung CR, et al
    Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    PLoS One. 2022;17:e0277087.
    PubMed     Abstract available


  70. TSAI HJ, Wong YS, Ong CT
    Clinical course and risk factors for sleep disturbance in patients with ischemic stroke.
    PLoS One. 2022;17:e0277309.
    PubMed     Abstract available


  71. TAKAYA Y, Nakayama R, Yokohama F, Toh N, et al
    Left atrial appendage morphology with the progression of atrial fibrillation.
    PLoS One. 2022;17:e0278172.
    PubMed     Abstract available


    January 2021
  72. KOOK H, Kim HD, Shim J, Kim YH, et al
    Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    PLoS One. 2021;16:e0244723.
    PubMed     Abstract available


  73. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
    The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
    PLoS One. 2021;16:e0245752.
    PubMed     Abstract available


  74. REZAEI-DARZI E, Mehdipour P, Di Cesare M, Farzadfar F, et al
    Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
    PLoS One. 2021;16:e0246253.
    PubMed     Abstract available


  75. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed     Abstract available


  76. SILAND JE, Nguyen BO, de With RR, Van Gelder IC, et al
    Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.
    PLoS One. 2021;16:e0246907.
    PubMed     Abstract available


  77. SCHMIDT MM, Griffin JM, McCabe P, Stuart-Mullen L, et al
    Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation.
    PLoS One. 2021;16:e0246861.
    PubMed     Abstract available


  78. QAZI JZ, Schnitzer ME, Cote R, Martel MJ, et al
    Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
    PLoS One. 2021;16:e0246691.
    PubMed     Abstract available


  79. XIAOKERETI J, Guo YK, Dong ZY, Ma M, et al
    Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model.
    PLoS One. 2021;16:e0247308.
    PubMed     Abstract available


  80. SHIYOVICH A, Chodick G, Azani L, Tirosh M, et al
    Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis.
    PLoS One. 2021;16:e0247097.
    PubMed     Abstract available


  81. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
    COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
    PLoS One. 2021;16:e0255976.
    PubMed     Abstract available


  82. CHAU E, Rosella LC, Mondor L, Wodchis WP, et al
    Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0245193.
    PubMed     Abstract available


  83. MATUZ A, van der Linden D, Kisander Z, Hernadi I, et al
    Enhanced cardiac vagal tone in mental fatigue: Analysis of heart rate variability in Time-on-Task, recovery, and reactivity.
    PLoS One. 2021;16:e0238670.
    PubMed     Abstract available


  84. CHO SS, Jo SH, Kim HJ, Lee MH, et al
    Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.
    PLoS One. 2021;16:e0248386.
    PubMed     Abstract available


  85. KOZIEL M, Teutsch C, Halperin JL, Rothman KJ, et al
    Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
    PLoS One. 2021;16:e0249524.
    PubMed     Abstract available


  86. LIN YC, Chen BL, Shih CM, Lin FY, et al
    Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.
    PLoS One. 2021;16:e0249940.
    PubMed     Abstract available


  87. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available


  88. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available


  89. ABAD R, Collart O, Ganesan P, Rogers AJ, et al
    Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry.
    PLoS One. 2021;16:e0249873.
    PubMed     Abstract available


  90. GOMES FREITAS C, Walsh M, Coutinho EL, Vincenzo de Paola AA, et al
    Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial.
    PLoS One. 2021;16:e0248567.
    PubMed     Abstract available


  91. ALAMMARI M, Sultana K, Alturaiki A, Thomas A, et al
    The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.
    PLoS One. 2021;16:e0250502.
    PubMed     Abstract available


  92. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available


  93. HAIDL H, Gaugler J, Cvirn G, Jasser-Nitsche H, et al
    Impact of electric cardioversion on platelet activation.
    PLoS One. 2021;16:e0250353.
    PubMed     Abstract available


  94. DHILLON GS, Ahluwalia N, Honarbakhsh S, Graham A, et al
    Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
    PLoS One. 2021;16:e0248951.
    PubMed     Abstract available


  95. JANG S, Ogunmoroti O, Zhao D, Fashanu OE, et al
    The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2021;16:e0248644.
    PubMed     Abstract available


  96. RAVVAZ K, Weissert JA, Jahangir A, Ruff CT, et al
    Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
    PLoS One. 2021;16:e0248134.
    PubMed     Abstract available


  97. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    PubMed     Abstract available


  98. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
    High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
    PLoS One. 2021;16:e0251178.
    PubMed     Abstract available


  99. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
    PLoS One. 2021;16:e0251124.
    PubMed     Abstract available


  100. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
    J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
    PLoS One. 2021;16:e0257982.
    PubMed     Abstract available


  101. GUO A, Smith S, Khan YM, Langabeer Ii JR, et al
    Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records.
    PLoS One. 2021;16:e0239007.
    PubMed     Abstract available


  102. SYOMIN F, Osepyan A, Tsaturyan A
    Computationally efficient model of myocardial electromechanics for multiscale simulations.
    PLoS One. 2021;16:e0255027.
    PubMed     Abstract available


  103. MASJEDI M, Jungen C, Kuklik P, Alken FA, et al
    A novel algorithm for 3-D visualization of electrogram duration for substrate-mapping in patients with ischemic heart disease and ventricular tachycardia.
    PLoS One. 2021;16:e0254683.
    PubMed     Abstract available


  104. REICHMANN-ARIEL D, Sadeh R, Galante O, Almog Y, et al
    Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava.
    PLoS One. 2021;16:e0252726.
    PubMed     Abstract available


  105. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available


  106. ROSENSTROM S, Risom SS, Ejlertsen C, Hove JD, et al
    Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study.
    PLoS One. 2021;16:e0254130.
    PubMed     Abstract available


  107. LIU XH, Xu Q, Luo T, Zhang L, et al
    Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies.
    PLoS One. 2021;16:e0253709.
    PubMed     Abstract available


  108. MALLADI CL, Darden D, Aldaas O, Mylavarapu PS, et al
    Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
    PLoS One. 2021;16:e0253266.
    PubMed     Abstract available


  109. SLAUGHTER MS, Monreal G, Koenig SC, Giridharan GA, et al
    Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
    PLoS One. 2021;16:e0253299.
    PubMed     Abstract available


  110. LEE HJ, Kim HK, Kim BS, Han KD, et al
    Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    PLoS One. 2021;16:e0253310.
    PubMed     Abstract available


  111. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available


  112. HAMMER KP, Mustroph J, Stauber T, Birchmeier W, et al
    Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice.
    PLoS One. 2021;16:e0252649.
    PubMed     Abstract available


  113. MISGANAW A, Sitote M, Jemal S, Melese E, et al
    Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0252465.
    PubMed     Abstract available


  114. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
    Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
    PLoS One. 2021;16:e0258313.
    PubMed     Abstract available


  115. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
    PLoS One. 2021;16:e0258377.
    PubMed     Abstract available


  116. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
    Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
    PLoS One. 2021;16:e0258285.
    PubMed     Abstract available


  117. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
    Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    PLoS One. 2021;16:e0258276.
    PubMed     Abstract available


  118. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
    The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
    PLoS One. 2021;16:e0255466.
    PubMed     Abstract available


  119. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available


  120. GARCIA-VILLAFRANCA A, Barrera-Lopez L, Pose-Bar M, Pardellas-Santiago E, et al
    De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review.
    PLoS One. 2021;16:e0258602.
    PubMed     Abstract available


  121. PIAYDA K, Afzal S, Nielsen-Kudsk JE, Schmidt B, et al
    Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.
    PLoS One. 2021;16:e0255721.
    PubMed     Abstract available


  122. RIVOLO S, Di Fusco M, Polanco C, Kang A, et al
    Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.
    PLoS One. 2021;16:e0259251.
    PubMed     Abstract available


  123. QIAN Y, Zhang J, Li J, Weng Z, et al
    A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
    PLoS One. 2021;16:e0259199.
    PubMed     Abstract available


  124. NEUBER JU, Pakhomov AG, Zemlin CW
    Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts.
    PLoS One. 2021;16:e0257287.
    PubMed     Abstract available


  125. CANNAVAN PMS, Cannavan FPS, Oliveira HC, Walfridsson U, et al
    A Brazilian Portuguese translation, cultural adaptation and validation of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) health-related quality of life (HRQOL) scale.
    PLoS One. 2021;16:e0256851.
    PubMed     Abstract available


  126. XIAO J, Zhang Y, Tang Y, Dai H, et al
    MiRNA-1202 promotes the TGF-beta1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.
    PLoS One. 2021;16:e0256066.
    PubMed     Abstract available


  127. REINHARDT SW, Desai NR, Tang Y, Jones PG, et al
    Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
    PLoS One. 2021;16:e0256338.
    PubMed     Abstract available


  128. LANKESTER J, Zanetti D, Ingelsson E, Assimes TL, et al
    Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study.
    PLoS One. 2021;16:e0255801.
    PubMed     Abstract available


  129. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available


  130. BAHRAMI RAD A, Galloway C, Treiman D, Xue J, et al
    Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach.
    PLoS One. 2021;16:e0259916.
    PubMed     Abstract available


  131. NAM KW, Kwon HM, Lee YS
    Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer.
    PLoS One. 2021;16:e0259627.
    PubMed     Abstract available


  132. WATANABE K, Nagata Y, Nitta G, Okata S, et al
    Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation.
    PLoS One. 2021;16:e0259750.
    PubMed     Abstract available


  133. YANAGISAWA D, Abe K, Amano H, Komatsuda S, et al
    Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    PLoS One. 2021;16:e0260585.
    PubMed     Abstract available


  134. STRUPPEK J, Schnabel RB, Walther C, Heydecke G, et al
    Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study.
    PLoS One. 2021;16:e0259652.
    PubMed     Abstract available


  135. MOTOC A, Luchian ML, Scheirlynck E, Roosens B, et al
    Incremental value of left atrial strain to predict atrial fibrillation recurrence after cryoballoon ablation.
    PLoS One. 2021;16:e0259999.
    PubMed     Abstract available


  136. SUBA S, Fleischmann KE, Schell-Chaple H, Prasad P, et al
    Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.
    PLoS One. 2021;16:e0261712.
    PubMed     Abstract available


  137. SAGER S, Bernhardt F, Kehrle F, Merkert M, et al
    Expert-enhanced machine learning for cardiac arrhythmia classification.
    PLoS One. 2021;16:e0261571.
    PubMed     Abstract available


  138. YOSHIKAWA M, Asaba K, Nakayama T
    Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2021;16:e0261020.
    PubMed     Abstract available


  139. LIU HT, Yang CH, Lee HL, Chang PC, et al
    Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients.
    PLoS One. 2021;16:e0260834.
    PubMed     Abstract available


  140. JANG JH, Kim TY, Lim HS, Yoon D, et al
    Unsupervised feature learning for electrocardiogram data using the convolutional variational autoencoder.
    PLoS One. 2021;16:e0260612.
    PubMed     Abstract available


  141. PATON MF, Gierula J, Lowry JE, Cairns DA, et al
    Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.
    PLoS One. 2021;16:e0259450.
    PubMed     Abstract available


  142. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
    Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
    PLoS One. 2021;16:e0260718.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: